7/17/24 16:30 | 7/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -266 | 124.67 | 0 | -2 | -3 | 60 | D | | | | | | | | | | | | | | |
6/17/24 16:30 | 6/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -27 | 79.77 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
5/15/24 17:09 | 5/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -26 | 76.89 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
4/17/24 16:30 | 4/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 61.24 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
3/15/24 16:30 | 3/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 60.48 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
2/15/24 16:30 | 2/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 55.31 | 0 | 0 | -1 | 58 | D | | | | | | | | | | | | | | |
1/18/24 16:30 | 1/16/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 56.01 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
12/15/23 16:30 | 12/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -26 | 75.62 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
11/15/23 16:30 | 11/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -22 | 63.57 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
7/21/23 16:30 | 7/19/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -159 | 90.87 | 0 | -2 | -3 | 60 | D | | | | | | | | | | | | | | |
5/17/23 16:31 | 5/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -38 | 99.36 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
4/19/23 17:33 | 4/17/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -34 | 88.67 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
3/17/23 16:30 | 3/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -28 | 71.58 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
3/8/23 18:44 | 3/6/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -628 | 72.52 | 0 | -9 | -12 | 63 | D | | | | | | | | | | | | | | |
2/17/23 16:30 | 2/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -22 | 57.52 | 0 | 0 | -1 | 60 | D | | | | | | | | | | | | | | |
1/19/23 16:45 | 1/17/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -20 | 52.97 | 0 | 0 | -1 | 61 | D | | | | | | | | | | | | | | |
12/19/22 16:31 | 12/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 53.75 | 0 | 0 | -1 | 61 | D | | | | | | | | | | | | | | |
11/17/22 16:30 | 11/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -23 | 59.00 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
10/19/22 16:30 | 10/17/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -27 | 70.50 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
9/19/22 16:30 | 9/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 85.83 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
8/17/22 19:43 | 8/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -32 | 82.82 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
7/19/22 16:30 | 7/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -105 | 70.86 | 0 | -1 | -2 | 63 | D | | | | | | | | | | | | | | |
6/17/22 16:31 | 6/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -24 | 62.87 | 0 | 0 | -1 | 64 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -84 | 52.08 | 0 | -2 | -2 | 65 | D | | | | | | | | | | | | | | |
3/2/22 21:09 | 3/1/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -116 | 48.04 | 0 | -2 | -4 | 61 | D | | | | | | | | | | | | | | |
2/17/22 16:30 | 2/15/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -36 | 28.64 | 0 | -1 | -2 | 60 | D | | | | | | | | | | | | | | |
1/20/22 16:30 | 1/18/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 26.93 | 0 | -1 | -2 | 61 | D | | | | | | | | | | | | | | |
12/17/21 16:30 | 12/15/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 26.72 | 0 | -1 | -2 | 62 | D | | | | | | | | | | | | | | |
11/17/21 16:30 | 11/15/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -38 | 30.47 | 0 | -1 | -2 | 64 | D | | | | | | | | | | | | | | |
10/19/21 16:30 | 10/15/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -29 | 23.71 | 0 | -1 | -2 | 65 | D | | | | | | | | | | | | | | |
9/17/21 16:30 | 9/15/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -30 | 24.55 | 0 | -1 | -2 | 66 | D | | | | | | | | | | | | | | |
8/18/21 17:10 | 8/16/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -32 | 25.46 | 0 | -1 | -2 | 67 | D | | | | | | | | | | | | | | |